Kim So Young, An Jae Jin, Kim Dae Won, Choi Soo Hyun, Lee Sun Hwa, Hwang Seok-Il, Kwon Oh-Shin, Kang Tae-Cheon, Won Moo Ho, Cho Sung-Woo, Park Jinseu, Eum Won Sik, Lee Kil Soo, Choi Soo Young
Department of Biomedical Sciences and Research, Institute for Bioscience and Biotechnology, Hallym University, Chunchon 200-702, Korea.
J Biochem Mol Biol. 2006 Jan 31;39(1):76-83. doi: 10.5483/bmbrep.2006.39.1.076.
Pyridoxine-5-P oxidase catalyses the terminal step in the biosynthesis of pyridoxal-5-P, the biologically active form of vitamin B6 which acts as an essential cofactor. Here, a human brain pyridoxine-5-P oxidase gene was fused with a gene fragment encoding the HIV-1 Tat protein transduction domain (RKKRRQRRR) in a bacterial expression vector to produce a genetic in-frame Tat-pyridoxine-5-P oxidase fusion protein. Expressed and purified Tat-pyridoxine-5-P oxidase fusion protein transduced efficiently into PC12 cells in a time- and dose-dependent manner when added exogenously to culture media. Once inside the cells, the transduced Tat-pyridoxine-5-P oxidase protein showed catalytic activity and was stable for 48 h. Moreover, the formation of pyridoxal-5-P was increased by adding exogenous Tat-pyridoxine-5-P oxidase to media pre-treated with the vitamin B6 precursor pyridoxine. In addition, the intracellular concentration of pyridoxal-5-P was markedly increased when Tat-pyridoxal kinase was transduced together with Tat-pyridoxine-5-P oxidase into cells.These results suggest that the transduction of Tat-pyridoxine-5-P oxidase fusion protein presents a means of regulating the level of pyridoxal-5-P and of replenishing this enzyme in various neurological disorders related to vitamin B6.
吡哆醇-5-磷酸氧化酶催化吡哆醛-5-磷酸生物合成的最后一步,吡哆醛-5-磷酸是维生素B6的生物活性形式,作为一种必需的辅因子。在此,将人脑吡哆醇-5-磷酸氧化酶基因与编码HIV-1 Tat蛋白转导结构域(RKKRRQRRR)的基因片段在细菌表达载体中融合,以产生基因内框Tat-吡哆醇-5-磷酸氧化酶融合蛋白。当外源添加到培养基中时,表达并纯化的Tat-吡哆醇-5-磷酸氧化酶融合蛋白以时间和剂量依赖性方式有效地转导到PC12细胞中。一旦进入细胞内,转导的Tat-吡哆醇-5-磷酸氧化酶蛋白显示出催化活性,并在48小时内保持稳定。此外,通过向用维生素B6前体吡哆醇预处理的培养基中添加外源Tat-吡哆醇-5-磷酸氧化酶,吡哆醛-5-磷酸的形成增加。此外,当Tat-吡哆醛激酶与Tat-吡哆醇-5-磷酸氧化酶一起转导到细胞中时,细胞内吡哆醛-5-磷酸的浓度显著增加。这些结果表明,Tat-吡哆醇-5-磷酸氧化酶融合蛋白的转导提供了一种调节吡哆醛-5-磷酸水平以及在与维生素B6相关的各种神经疾病中补充这种酶的方法。